Oral bisphosphonate use cuts risk of post-implant revision Sx
(HealthDay)—For patients undergoing total joint replacement, oral bisphosphonate use is associated with a reduction in the risk of revision surgery, according to a study published in the November issue of Arthritis & Rheumatology.